WST West Pharmaceutical Services Inc

$268.18

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Website: https://www.westpharma.com

Sector
MANUFACTURING
Industry
FABRICATED RUBBER PRODUCTS, NEC
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
105770
Address
530 HERMAN O. WEST DRIVE, EXTON, PA, US
Valuation
Market Cap
$14.60B
P/E Ratio
30.22
PEG Ratio
3.38
Price to Book
5.44
Performance
EPS
$6.68
Dividend Yield
0.42%
Profit Margin
17.00%
ROE
17.70%
Technicals
50D MA
$229.60
200D MA
$293.32
52W High
$393.65
52W Low
$187.43
Fundamentals
Shares Outstanding
72M
Target Price
$284.51
Beta
1.22

WST EPS Estimates vs Actual

● Estimated
● Actual

WST News & Sentiment

Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
Sep 29, 2025 • Zacks Commentary SOMEWHAT-BULLISH
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Sep 25, 2025 • Zacks Commentary BULLISH
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
Sep 23, 2025 • Zacks Commentary BULLISH
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
Sep 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Sep 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Sentiment Snapshot

Average Sentiment Score:

0.049
50 articles with scored sentiment

Overall Sentiment:

Neutral

WST Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
0.19 Surprise
  • Reported EPS: $1.45
  • Estimate: $1.26
  • Whisper: —
  • Surprise %: 15.3%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $1.82
  • Estimate: $1.71
  • Whisper: —
  • Surprise %: 6.4%
Oct 24, 2024
Sep 30, 2024 (Pre market)
0.35 Surprise
  • Reported EPS: $1.85
  • Estimate: $1.50
  • Whisper: —
  • Surprise %: 23.3%
Jul 25, 2024
Jun 30, 2024 (Pre market)
-0.22 Surprise
  • Reported EPS: $1.52
  • Estimate: $1.74
  • Whisper: —
  • Surprise %: -12.6%
Apr 25, 2024
Mar 31, 2024 (Pre market)
0.3 Surprise
  • Reported EPS: $1.56
  • Estimate: $1.26
  • Whisper: —
  • Surprise %: 23.8%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $1.83
  • Estimate: $1.78
  • Whisper: —
  • Surprise %: 2.8%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $2.16
  • Estimate: $1.86
  • Whisper: —
  • Surprise %: 16.1%
Jul 27, 2023
Jun 30, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $2.11
  • Estimate: $1.93
  • Whisper: —
  • Surprise %: 9.3%
Apr 27, 2023
Mar 31, 2023 (Pre market)
0.31 Surprise
  • Reported EPS: $1.98
  • Estimate: $1.67
  • Whisper: —
  • Surprise %: 18.6%

Financials